Hits and Misses

Milton Friedman’s legacy.

Tom Miller is disappointed in the Coburn/Burr/Hatch health reform bill.

South Korea will not regulate Samsung’s Galaxy S5 (a smartphone with a heart-rate sensor) as a medical device. (See also previous blog entry)

Medicare Advantage cuts: Insurers’ advocacy campaign contradicts Wall Street analysts’ rosy outlook.

Comments (7)

Trackback URL | Comments RSS Feed

  1. Eisenhower says:

    “This could lead to a similar process to that of the US, where consumer pulse sensors are not subject to approval from the Food and Drug Administration.” That will be more efficient.

  2. Thomas says:

    Milton Friedman certainly left a legacy behind in economics, and will be remembered as one of the most influential, if not the most, influential economists of our time.

    • Matthew says:

      “Some argue that Friedman’s free market ideas were utopian, out of touch with political reality.”

      Probably out of touch with political reality, but on point for an efficient economy.

  3. Andrew says:

    “…it is underdeveloped and does not accomplish any sort of meaningful reform.”

    Although we need to repeal and reform Obamacare, substituting it with some last minute amalgamation is not a good policy solution.

    • James M. says:

      I agree that the Republican alternative is overdue, but over focusing on political concerns against Obamacare is not the correct way to approach their reform.

  4. Bill B. says:

    Until people start to use the Samsung Galaxy as an alternative to a medical device, then it should be regulated as such.

    • Walter Q. says:

      But people are. If it monitors blood glucose and blood pressure, it can be used as a medical device. It would be irresponsible for consumers to use the products as such with no regulation to back it up.